Applera Accelerates Old Options Vesting

Applera’s board of directors has approved acceleration of the vesting of stock options held by employees and directors, the company said in an SEC filing last week. Options with vesting based on performance and those held by employees in certain foreign companies were not accelerated, the company said. The shares received on exercise held by directors and senior management may not be sold any earlier than the original vesting date, or upon termination.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.